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Abstract
Currently in America 1 out of every 10 residents suffers from diabetes, and this tendency
is likely to grow up to “1 of every 3” by the year [6]. Diabetes exhibits several complications. In
2005, the lead cause of stroke and heart disease was diabetes, 68% of the cases [1]. In 2008, 44%
of kidney failure was associated with diabetes [1]. 60 to 70 % of cases of diabetes have a mild to
severe nervous system damage [1]. Diabetic patients who have developed peripheral neuropathy
tend to also develop foot ulceration. In an advanced stage a foot ulcer can lead to limb
amputation. More than 60% of non-traumatic lower-limb amputations occur in people with
diabetes [1].
There is a great need to develop efficient and reliable measurements for foot ulceration.
By the use of novel sensory techniques [19], this study has provided an efficient and reliable
measurement for foot ulceration that will lead to sensory feedback for brain plasticity. This study
used an instrumental treadmill from Bertech ®, a Delsys® surface Electromyograph, an insole
system from Teck-scan®, to monitor the conditions of the diabetic foot by measuring the Foot
Pressure, electrical activities of the muscles (EMG), and the ground reaction forces (GRF). The
ultimate goal of the study was to provide accurate and reliable information to medical doctors for
an early diagnosis to improve the quality of life of the diabetic patients.
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Chapter1: Introduction
Currently 1 out of 10 Americans has type 2 diabetes [1]. It has been predicted that by
2050 one out of every three Americans will suffer diabetes if there is not a dramatic life style
change. In 2010, U.S. residents within ages of 65 and older (26.9% of the entire population in the
U.S.) had diabetes [1]. In the same year 215 people aged 20 years old or younger, were
diagnosed with type 1 or type 2 diabetes. Diabetes is the number one cause of kidney failure,
blindness, heart disease, stroke, and non-traumatic lower limb amputation [1]. Table 1.1 is an
extraction from the Centers for Disease Control and Prevention, website from the 2010 statistics.
Table 1.1: Centers for Disease Control and Prevention 2010 Statistics

http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf
These figures speak for themselves and each year there is 1.9 million new cases of
diabetes. 60-70% of the people with diabetes have a mild to severe form of nerve damaging
peripheral neuropathy (PN). This type of nerve damage is commonly known as “Diabetic Foot”
[15].
Diabetic foot is made up of various types of pathologies ranging from diabetic
neuropathy, peripheral vascular disease, foot ulceration, to potential limb amputation [1]. A
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person that suffers diabetes has a 60-70% risk of developing a foot ulcer. More than 60% of nontraumatic lower-limb amputations occur in people with diabetes [1].
Amputation is the final stage of diabetic foot, which is associated with significant
morbidity and mortality, besides having immense social, psychological and financial
consequences. Valuing the diabetic foot represents a very important element of the annual
diabetic review. It is indeed crucial to identify the foot at risk at the earliest stage possible, so as
to target preventive and therapeutic measures. This approach not only helps in reducing the
significant morbidity and mortality associated with diabetic foot disease, but also represents
major health care-associated economic benefits [1].
The main goal of this study is to provide a reliable and efficient method for monitoring
the condition of the diabetic foot. This investigation monitored dynamic data of the diabetic
patients, such as: the muscular activity in the lower limbs, GRF in 3 axes during a dynamic test,
and irregular high pressure in the foot sole.
This investigation focused on finding abnormal behavior including inadequate muscle
activation during the gait cycle, irregularities in the GRF, and extreme high pressures in the footsole, since these are the exhibited characteristics of diabetic patients with peripheral nerve
damage. This study also investigated into the differences between walking over ground and on
an instrumented treadmill (from Bertec ® inc.). By using the integration of multiple sensors, the
information acquired from the one system is able to validate that of the other and vice versa. This
is by virtue of the synchronization of the system at the acquisition period. It is indeed crucial to
identify the foot at risk earlier, so as to target preventive and therapeutic measures at the earliest
opportunity.
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Chapter 2: Motivation, Why do this?
According to the American Diabetic Association, 25.8 million adults and children (or
7.8% of the population) have a form of diabetes in 2010 [1,15]. In the same year 18.8 million
people were diagnosed with diabetes, and 79 million people were diagnosed as a pre-diabetic.
From the American Diabetic Association statistics 60 to 70% of diabetic patients tend to develop
peripheral neuropathy (PN) which results in nerve damage. 50% of diabetic patients who have
developed the PN are asymptomatic, putting them at risk of injury [15]. The combination of
nerve damaging and injury may result in foot ulceration and in severe cases to lower limb
amputation. 60 % or more of the non traumatic amputation in the lower extremities occurs in
people with diabetes [1]. Amputation is the endpoint of diabetic foot disease, which is associated
with significant morbidity and mortality, besides having immense social, psychological and
financial consequences.
The tremendous shock of losing a limb or being at the constant tread of losing it, impacts
strongly into the patients and their families. This fear causes emotional disorder as anxiety and
paranoia. The impact of losing a limb can immerse the diabetic patient into a depression,
lowering his/her immune system. As a result of this, their physical recovering will be longer.
Economically, after an amputation there is the additional need for special adaptation to their
homes and vehicles, aside from the enormous medical fees. These special needs can be
extremely expensive and some diabetic patients will not be able to afford them. The lack of these
new and special needs will limit their daily lives ultimately reducing their quality of life. Each
year the number of diabetic cases increases. This creates a great need, to develop efficient and
reliable methods to measure foot ulceration.
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Chapter 3: Specific Aim and Hypothesis
Our current society faces an epidemic of diabetes and its many consequences. To
improve the life quality of our citizens, it is necessary to provide reliable and accurate dates with
medical doctor, to provide the best possible decision for their diagnosis. Techniques used on
daily bases by physicians to detect the possible areas where the diabetic patient can develop an
ulcer, are semi-quantitative. We refer to the SW-monofilament and sensation vibration test as
semi-quantitative since they relay on the experience and skills of those who apply the test as well
as in the feedback of the patient. This thesis proposes to produce efficient and reliable
measurement of foot ulceration that may be used to provide the required sensory feedback for the
brain plasticity. This technique integrates the different signals from the multiple sensors. By
enabling the data collection of the different systems simultaneously, the acquired data of one
system can validate the data of others and vice versa.
Therefore, the main goals of this research project are:
•

To monitor the diabetic foot through the measurement of Foot Pressure, EMG, and GRF.

•

To efficiently and reliably measure the pressure in foot sole to avoid foot amputation.

•

To measure to enable a compensatory strategy based on sensor feedback.
The ultimate goal of this investigation is to provide valuable data to the physician. This

will aid the physician to provide an early diagnosis of diabetic foot since this data contains
quantitative information in comparison to the current devices and methods. This will help the
diabetic community to improve their quality of life. This approach does not merely help in
reducing the significant morbidity and mortality associated with diabetic foot disease, but also
could have major health care-associated economic benefits.
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Chapter 4: Background and Relevance
As diabetes progresses (Figure 2.1), the patients become exposed to higher glucose levels
and this condition is then called Hyperglycemia. Hyperglycemia is one of the major
complications of diabetes mellitus and can lead to an abnormal metabolic process which affects
the Schwann cell (nerve cells which conduce electrical activity in neurons), nodes of Ranvier
(joins of the Peripheral nerve system) [11], and microvessels damage (Peripheral vascular
disease)[11]. The deterioration of the aforementioned cells can result in PN, Autonomic or
Somatic. From the information provided by the Centers for Disease Control and Prevention in
Chapter one, the autonomic neuropathy can attack all body systems such as cardiovascular
system, visual system, renal system etc. One of the many systems affected in this case is the skin
[15]. After the diabetic patient develops the PN autonomimic, the skin becomes dry and losses
elasticity, that is, it becomes fragile, and as result the skin gets susceptible to injures. With this
delicate skin condition the diabetic patient becomes susceptible to injuries [14,15]. The skin is
fragile enough that even irregularities in their shoes can cause laceration. Any laceration can
easily become infected and become a foot ulceration [14].
Somatic PN leads to a progressive loss of somatosensory sensitivity due to the nerve
damage, proprioception and distal muscle function specially in lower limbs [11]. This loss of
sensation can progress to a stage where the diabetic foot loses the protective sensation in the foot
sole. Once the protective sensation is lost, the diabetic patient can get injured even without any
knowledge of the laceration. Also, due to muscle dysfunction, their walking pattern is affected
that leads to the development of the problem of the drop foot. These irregular locomotion
increases their risk of getting injures. Any lacerations in the combination of somatic PN can
quickly be infected if it not constantly monitored [3,4].
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The degradation of the microvessels produces a reduced blood flow to the lower limbs
producing ischemia or hypoxia [15]. Once the Ischemia is present, the feet of the patient get
susceptible to injure easily. The combination of ischemia and any injury can lead rapidly to a
foot ulcer. Due to the absence of sufficient blood in the wound, the healing process becomes
slower, opening a window for infections. In the worse case, foot ulcers in the patients can lose
the limb. Current statistics show than 80% of ulceration cases in lower-limbs end in the
amputation of it [1].

Figure 4.1: Diabetic Foot development
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Chapter 5: State of the Art
5.1 Foot Pressure in the Foot Sole
In the last decade, several scientists and medical researchers have conducted
investigations and developed techniques to quantify and diagnose the potential risk of diabetic
foot. Among these techniques is also the measurement of the distribution of pressure in the foot
plantar dynamically and statically. Once a patient develops PN there arises the gradual loss of
plantar sensation causing motor alterations and leading to abnormal high pressures in the foot
plantar [4]. From the research conducted by Antonella Caselli and colleagues, it was found that
both the rear-foot and fore-foot pressures are increased in diabetic neuropathic foot [4]. Although
these findings confirmed their hypothesis, some other relevant details were missing such as the
EMG. Hence, this study monitored the GRF in three planes, but also we cross validate our GRF
data with the F-scan data and EMG. This study provides the perspective of three reliable systems
monitored the same problem.
5.2 Ground Reaction Force GRF
As consequence of the locomotion alteration due to the progress of the peripheral
neuropathy, diabetic patients show mechanical difficulties during loading-off phase during the
gait cycle [9]. A study conducted by Robert Van Deursen showed a significant small second
peak characteristic of the off–loading phase in the vertical GRF [9]. This research took in
consideration Deuresen‟s findings as well as the monitoring of the dynamic forces in the three
planes.
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5.3 EMG
A further complication related to the diabetic foot is an alteration of the motor controls in
the lower extremities. Paula M.H. Akashi and colleagues found a delay on the activation of the
lateral gastrocnemius (LG) and vastus lateralis (VL) during the gait cycle [4,10]. The EMG data
and the vertical GRF were simultaneously collected. Due to the cases of progression and
worsening of the PN, an alteration in the second peak of the vertical GRF was found that related
to the delay in the EMG. The second peak of the vertical GRF becomes a function of the pushoff phase [4,10]. This study bears some level of similarity to the one depicted in [4,10]. The
distinguishing difference about the current study involves the implementation of other added
strategies, the collection of the GRF in three planes (Mediolateral (FX), anterioposterior (FY),
and vertical (FZ)), the 16 channel surface electromyography (sEMG) for monitoring the
activities of eight muscles per limb. This strategy provides a robust and detailed data to the
medical doctors to assist their diagnosis of diabetic foot.
5.4 SW monofilament, Biration Sensation (Tuning Forck and Biotesimeter)
To detect the possible areas of ulceration, clinicians use tools, the Semmes Weinstein
(SW) monofilament Biothesiometer, and the Tuning Fork. There are many different types of SW
monofilament measures. The most used are: 2.83, 3.61, 4.17, 4.6 5.07, and 6.1 (0.07, 0.4, 4.0,10,
and 75 grams of force respectively) Clinical Usefulness [16,17]. Each one of them corresponds
to a level of severity (normal, impediment to touch, impediment to protective sensation, lost of
protective sensation, and untestable). SW monofilament tests (Figure 5.1) the patient‟s ability to
sense a specific point of pressure in certain areas of the foot plantar such as the first, third, fifth
metatarsal, toes, medial and lateral foot, and the heel. The patient is often asked of the sensation
based on a pinch. This procedure is at least performed twice using the five monofilaments.
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Figure 5.1: Monofilament and areas of testing.

The tuning fork (Figure 5.2b) provides a vibration sensation test. It vibrates at 128 Hz
during the test and it is placed in a perpendicular position with respect to the test area [15]. The
tested areas are: first, third, fifth metatarsal, toes, medial as well as lateral foot and the heel
(same areas test with SW monofilament). The tested areas are randomly chosen and they are
usually tested three times. There is a possible risk of ulceration if the patient fails two times.
The Biothesiometer (Figure 5.2a) provides an evaluation of the vibration perception
threshold (VPT). This medical tool vibrates at 100 Hz and it measures in a linear scale of 0-50
Volts [24]. This device targets same areas as the SW monofilament and tuning fork. While the
patient is being tested, it is held against each one on the areas of interest. If a patient could not
detect a value above 25 V he/she is considered being at risk of foot ulcer [15].
However, these tests are still not a complete quantitative measure. They rely on constant
calibration, verbal feedback from the subject and the experience of the clinician or therapists at
performing and interpreting the results of the test.
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Figure 5.2: Biothesiometer (a) and Tuning Fork (b).
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Chapter 6: Method
6.1 Experimental Design
To accomplish the aims of this research, three different systems were used along with the
technique.

Figure 6.1: Sensor fusion driven computational intelligence scheme.

Figure 6.1 illustrates the three systems and their respective sensors which monitored
different physiological aspects of all the participants. The muscular activity was monitored by
using a Bagnoli™ Desktop EMG Systems from Delsys ® inc. This was a 16 channels surface
Electromyogram. The EMG measured the electrical activities of the eight muscles in both the left
and right limbs. These muscles are: soleus (Sol), tibialis anterior (TA), gastrocnemius lateralis
(LG), vastus lateralis (VL), rectus femoris (RF), biceps femoris (BF), gluteus medius (Gmed),
and erector spinae (ES). Muscular activity can provide useful information in the prevention of
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diabetic foot. According to Paula M.H Akashi and her colleagues [2], diabetic neuropathy affects
specifically the motor controls of the lower extremities during gait and static posture due to a
gradual loss of somatosensory sensitivity, proprioception and distal muscle function. These
irregularities were found as a delay in time of the lateral gastrocnemius and vastus lateralis [2].
For this research study eight muscles were monitored, since we consider this set of muscles can
provide a more accurate and robust data.
The F-scan insole from Tekscan® was used to acquire the foot pressure distribution in
the foot sole. Previous research work conducted by Antonella Caselli and colleagues have shown
that high plantar pressure is a strong indicator of diabetic foot [2]. It can also be conceived that
irregular high pressure peaks and the frequencies of their reoccurence in the static and dynamic
measure can be used as another good indicator of diabetic foot [4,10]. The areas target by the Fscan will be the Big toe, Metatarsal 1, Metatarsal 2, and Heel. The selected areas were 4 by 4 cm.
These areas are the same areas tested in SW-monofilament. The results of the SW-monofilament
will be used to cross validate the out the F-scan.
When a Diabetes Mellitus (DM) patient develops PN a gradual loss of sensitivity occurs
in the foot plant. Through the foot plant sensitivity the brain modulates the strike force of the feet
on the ground. An alteration to the GRF could be used as an indicator that a DM patient is at risk
of developing diabetic foot [9]. GRF can show if the subject is applying excessive amount of
force which results in loss of plant sensation [9]. For this study a double belt instrumental
treadmill from Bertec was used to capture the GRF data of each participant (healthy and diabetic
patient) in three different planes: Fx (mediolateral), Fy (anterior posterior), and Fz (vertical).
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6.2 Subjects
Seventeen healthy volunteers without diabetes and any motor impairment in the lower
limbs participated in this study. Twelve of them were male within the ages of 24-36 years, while
6 of them were female between 25 and 38 years. This study also included a total of 11 volunteers
with diabetes mellitus. Six of them were female within the age range of 41 and 67 years old, and
five males between 43 and 67 years, respectively. These patients were recruited based on the
approval of the UTEP Institutional Review Board (IRB). The diabetic patient (DP) group was
gathered under the following criteria: at least three years of being diagnosed of Type 2 diabetes;
No motor impairment in the lower extremities; No history of foot ulceration.
Before any data was collected, all the volunteers (Healthy and Diabetic), read carefully
our inform consent form which also contains the IRB to conduct this type of investigation. The
volunteers gladly signed it after they accepting all the terms and conditions.

Table 6.1: Anthropometric data of the Control group.
Age
(Yrs)

Height
(cm)

FH01

38

165

FH02
FH03

25
27

FH04
FH05
FH06

Female

Weight (Kg)

Height
(cm)

Weight
(Kg)

26

74

167

26.5

MH02
MH03

30
24

90.1
67

171
176

30.8
21.6

33.9

MH04

31

193

92.2

24.8

24
23.9

MH05
MH06

24
25

185
164

8.3
81.5

22.9
30.3

MH07

24

178

77.5

24.5

MH08
MH09

28
25

182
184

88.2
77.6

22.2
22.9

MH10

36

174

84.6

27.9

BMI(kg/m2)

Male

58.5

21.5

MH01

155
153

54.4
49.5

22.6
21.1

27

165

92.3

26
26

154
168

57
67.5
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Age (Yrs)

BMI(kg/m2)

Table 6.2 : Anthropometric data of the type 2 diabetes group without motor impairment.

Female
PF01
PF02
PF03
PF04
PF05
PF06
PF07
PF08

Age (Yrs)

Height
(cm)

Weight
(Kg)

56
60
67
41
63
63
40
54

153
155
146
153
150
164
153
157

67.5
94.2
71.9
75.2
74.4
79.2
79.4
79.9

BMI
(kg/m2)

Years of Bing
Diagnosed

28.8
39.2
33.7
32.2
33.1
29.4
33.9
32.4

5
21
15
9
6
20
6
4

Male

Age
(Yrs)

Height
(cm)

Weight
(Kg)

BMI
(kg/m2)

PM01
PM02
PM03
PM04
PM05

43
65
61
67
47

179
176
187
160
161

96.6
78.5
137
86
75.9

30.2
25.3
39
33.6
29

Years of Bing
Diagnosed
6
30
20
12
10

6.3 Experimental Procedure
A detailed procedure was explained to every participant (DP and Healthy) prior to the
performance of the procedure. Every participant wore running shorts. Preliminary
anthropometric data was taken from each subject. After this, all three systems were attached onto
the subject as described next.
6.4 Software Set Up
LabVIEW software of Texas Instruments was used to synchronize the simultaneous data
collection and set the frequencies of acquisition. The Delsys Inc. ® surface EMG was set at
1000Hz [2, 8]; the Tri-axial Accelerometer-Gyroscope and the instrumental treadmill were set at
100Hz. The F-scan was also set at 100Hz according to the treadmill speed. The F-scan has its
own software “Fscan Research 7.52”.
6.5 Sensor Placement
EMG
The surface electromyographic (sEMG) electrodes were allocated over the following
muscles (Figure 6.2): soleus (Sol) over posterior side of the leg, parallel to the muscle fiber.
Tibialis anterior (TA), placed between the knee and ankle, lateral to the tibia bone.
14

Gastrocnemius lateralis (LG), placed on upper half of the posterior aspect of the calf. Vastus
lateralis (VL), placed in the lower end of the thigh, approximated 6 cm above the kneecap.
Rectus femoris (RF), the electrode is placed on the thigh between the hip bone and knee. Biceps
femoris (BF), the electrode is placed half way between the ischial tuberosity and the lateral
epicondyle of the tibia. Gluteus medius (Gmed), the electrode is placed three centimeters
towards the spin, going from the hip bone. Erector spinae (ES), the electro is placed to two cm
from L1 [19].

Figure 6.2: EMG Electrode placement on the lower extremity.

F-scan
All subjects brought their own comfortable shoes and the insoles were inserted in them
accordingly. The insole sensor covered all the area of the foot sole for an effecting collection of
the pressure data, especially in our areas of interest.
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Figure 6.3: Fscan system (a) and insoles (b).

6.6 Instrumental Treadmill
The instrumental treadmill was initialized. Subsequent to the calibration and sensor
placement, the volunteers were asked to walk on the instrumental treadmill to familiarize with it.
This also enabled the determination of the subject‟s natural walking speed.
6.7 Triggering
The different systems were triggered synchronously to enable simultaneous capture of the
sensor data. To perform this triggering and acquisition of data, a Labview program was built for
the treadmill and EMG. This program enabled the simultaneous data collection and the triggering
of the F-scan.
The output of this program was a simultaneous triggering of the three systems. Before
each trial started, it was necessary to run a pretest to ensure the systems enabled and operated
properly. During the data collection the research team acknowledged that any type of delays
needed to be avoid since them can result in fatigue and in bad measure.
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6.8 Trials
The trials started by asking the participants to step in to the treadmill. At this point all the
sensors were placed and most of the device and software calibration were done. To complete the
calibration of the Fscan insoles, the software of Tekscan® was opened and the weight (in
kilograms) of the volunteer was added to the software (this was used to normalize the pressure
according to each subject). While these parameters were introduced to the software the
participant needed to stay steady for six seconds.
The treadmill was set at the natural pace of each subject (previously obtained) and then
collected 100 seconds of data using the four systems. If during the trial the participant was
insecure of their ability to keep balance while the treadmill was running, a security harness was
providing to them. At all times on of the research, the team was behind the volunteers in case of
any emergency.
The software was set to proceed with the rest of the trials before the over ground trials
started. Five overground trials were recorded using the sEMG and Fscan. Each one of the
overground trial was approximately five meters in length. Between trials the data was saved and
revised in order to proceed with the next trial. The complete procedure took about one hour.
Subjects were able to dictate when they were ready to proceed with each test and were given a
resting period of at least five minutes between each trial.
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Chapter 7: Data processing

7.1 Analysis
The processing of the acquired data was performed after its acquisition. The data were
categorized according to the type of trial performed.
EMG
The process of filtering the EMG raw data (Figure 7.1) consisted of three stages. In the
first stage a forth order Butterworth band pass filter with a cut off frequency from 20 to 300 Hz
was applied to the raw data as shown in Figure 7.2. According to De Luca in 1997 [8] between
these frequencies the most significant power is set [19]. The next two stages consisted of a
technique called “envelop technique” which applies a full wave rectifier and low pass filter. Full
wave rectifier is an elegant form to refer to an absolute value (figure 7.3). A fourth order
Butterworth low pass filter, with a cut off frequency of 4 Hz (Figured 7.4) was the last stage in
this processes.
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Figure 7.1: Raw signal of Right Soleus.

Figure 7.2: First stage of process Band pass filter.
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Figure 7.3: Full wave rectifier EMG.

Figure 7.4: Last stage of EMG filtering Low pass filter.
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Fscan
Using the Tekscan® software tools, the previously mentioned four areas in each foot
were selected manually. Figure 7.5 exemplifies the selection of these areas.

Figure 7.5: This software target the Heel (pink), Big Toe (Green), and Metatarsals one (Red) &
two (Blue).

The areas of the boxes were 4cm by 4cm, the position of them were changed to fit the
specific size of each participant feet.
An individual excel file was created for each foot. These files contained six columns, first
column is the frame number, the second column the time in seconds, and the last four contained
the data related to the pressure in each of the four areas given in PSI.
Still at this point the data had to be filtered to eliminate some extra noise. By applying a
second order Butterworth filter with a cutoff frequency of 7Hz most of the noise produced by the
mechanical parts and bends of the insole and other sources of noise were eliminated.
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Figures 7.6a and 7.6b show the enhancement filtered data in comparisons to the raw data from
right heel of one of our control group participants.

Figure 7.6: Raw data (a) and Filter data (b) from right foot heel of a control group volunteer.

Ground Reaction Force (GRF)
The instrumented treadmill is a precise machine, whose outputs data requires no complex
filtering. As in the F-scan the noise produced by the mechanical parts of the treadmill and some
other white noise were easily removed by applying a second order Butterworth of a cut off
frequency 20 Hz. The following Figures 7.7a and 7.7b illustrate the improvement of the data
quality.

Figure 7.7: Raw data (a) and Filter data (b) from right foot in the vertical axis of a control group
volunteer.
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All the filter techniques used to process different raw data had as main goal to enhance
the data through getting rid of most the noise without affecting the phase and amplitude of the
original data. This will provide accurate and detailed information which in a near future can aid
medical doctors.
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Chapter 8: Feature Extraction
8.1 Data Re-sampling
Since none of the participants (healthy or patient) could repeat precisely and continually
each gait cycle at the same length, it was necessary to interpolate each of them at exactly 100
points of data. The mathematical technique of interpolation consists of constructing new data
points within the range of a known set of data points [7]. Using the mathematic tool of Matlab
“spline” all the data sets were resampled. These gait cycles were extracted by using another
method different the interpolation. This was made to corroborate that the significant
characteristics of the data (such as the amplitude) were not distorted or contaminated. This
method was applied to all the data since it is fast and efficient. Once all the gait cycles were
extracted they were averaged, producing a new matrix which is representative of the complete
trial (treadmill or overground depending which file was used). This resampling and averaging
method were applied to the filtered output data of the systems.
EMG
To properly re-sample the EMG, it was necessary to use the GRF at the Z axis (vertical)
to separate the EMG data into the strides. Each muscle needed to activate at a specific time
during the gait cycle (this is if the person does not suffer any motor impairment or disease which
can affect the proper activation such as “Diabetes” Figure 8.1 shows the proper pattern of
activation during the gait cycle) [19].
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Figure 8.1: Muscle activation during the gait cycle in percentage.

Each muscle was processed by using the same resampling technique. After processing
100 seconds of collected data, each muscle from right and left leg was averaged individually to
provide a characteristic matrix and plot of the muscle.

Figure 8.2 shows the plot of the

characteristic muscle activity during the 100 seconds test over the treadmill.
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Figure 8.2: Characteristic plot of the right Sol of one volunteer from the control group during the
100 seconds trial.

Once all the members of the control group were processed, all the females and males
were averaged into a knowledge base which was used as a reference point to compare in a future
the level of impairment. The bigger the population grows the more accurate it will be. Figure 8.3
shows the current knowledge base for males, while Figure 8.4 represents the knowledge base for
the female subjects.
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Figure 8.3: EMG Knowledge base of female control group.

Figure 8.4: EMG Knowledge base of male control group.
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Fscan
After the extraction and filtering stage, the next step was to extract the maximum
pressure point from the areas of interest. The filter data was also normalized by the relative
velocity of the participant. The relative velocity was obtained using the simple formula of
where „x’ is equal to the stride length and „t‟ was the time of stride. The stride length was
estimated to one meter for all the participants healthy and patients. The time of the strides was
obtained by placing a time index at the maximum point of the peak pressure on the heel, and then
subtracted from the time index from the previous stride. A new matrix of time was generated and
then averaged to obtain a single value for the time. This process was applied individually to the
right and left leg, since we know that there is always a difference between them. Simultaneous
to the process of obtaining the time, each of the maximum values of pressure was extracted and
stored in a matrix tag as the area that was being processed. Before extracting the peak pressure,
the data was resampled using the re-interpolation method mentioned at the beginning of this
section. To extract the time the data was resample since this would produce a false time.
After all the healthy participants’ pressure data was extracted in all the four areas, they
were averaged to create a pressure range for to diabetic participants. The following tables
provide in detail the pressure data over the treadmill of all of the males and females patients and
the range generated by the healthy group.
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Table 8.1: Male Diabetic patients average of the max press over the instrumental treadmill and
Knowledge base.

Patients
PM01
PM02
PM03
PM04
PM05

mean/std

Big Toe
Right
Left
26.43(08.20)
31.28(07.80)
121.73(37.18) 145.71(54.90)
119.58(15.85) 107.59(40.15)
79.30(16.93)
70.57(28.04)
136.17(21.31) 192.03(39.39)
Healthy Participants
Big Toe
56.20 / 25.20

M1
Right
Left
53.04(06.11) 53.23(08.89)
69.54(08.49) 65.26(27.29)
96.35(12.04) 38.90(06.90)
73.08(20.96) 65.18(19.16)
74.10(14.91) 34.94(16.55)

Right
43.65(08.23)
59.53(13.83)
74.33(11.34)
62.58(08.37)
116.17(24.29

M1
65.19 / 18.61

M3
Left
57.04(10.71)
134.23(21.03)
165.47(35.49)
27.78(04.84)
134.10(41.15)

M3
48.67 / 20.30

Heel
Right
Left
40.11(07.29)
22.17(05.47)
49.57(14.00)
59.82(12.54)
89.15(11.51)
42.39(07.91)
39.16(09.47)
28.95(06.00)
105.33(33.86) 189.58(41.22)
Heel
64.50 /15.99

minimum

22.08

39.94

17.26

42.66

maximum

126.56

102.16

95.34

95.31

Table 8.2: Female Diabetic patients average of the max press over the instrumental treadmill and
Knowledge base.

Patients
FDM01
FDM02
FDM03
FDM04
FDM05
FDM06
FDM07
FDM08
FDM09

Big Toe
Right
Left
49.00(15.18)
103.18(44.84)
85.81(25.66)
46.53(21.69)
216.82(82.67) 44.39(14.39)
20.24(6.45)
38.35(15.57)
35.99(2.98)
33.54(4.48)
75.65(31.60)
96.81(52.05)
168.58(26.93) 26.07(10.41)
64.04(22.94)
46.96(8.93)
194.80(65.42) 41.66(10.14)
Healthy Participants
Big Toe

mean/std

39.49 / 19.60

M1
Right
Left
37.22(8.34)
80.40(16.12)
107.07(9.76)
86.15(12.31)
62.90(17.02)
40.81(18.05)
74.71(24.66)
78.60(27.13)
34.76(2.85)
25.44(5.12)
48.49(5.78)
95.19(14.83)
102.16(23.
37.49(6.70)
113.77(15.03) 126.42(15.87)
206.93(38.53) 40.14(7.11)

M3
Right
Left
33.10(8.72)
64.52(15.89)
79.39(17.45)
68.52(15.41)
78.22(28.15)
62.05(28.59)
34.80(9.97)
52.42(39.56)
21.38(6.16)
22.29(5.44)
51.76(6.51)
86.03(15.48)
51.32(14.39)
29.95(8.38)
73.19(13.36)
71.52(10.94)
321.47(49.99) 52.45(10.55)

Heel
Right
Left
30.52(13.03)
29.95(9.36)
37.43(9.62)
20.05(5.96)
117.25(33.29) 146.11(64.28)
36.33(6.08)
42.31(10.31)
23.16(5.83)
22.33(5.43)
35.05(13.03)
46.71(20.25)
78.05(22.95)
67.03(13.19)
47.11(7.19)
43.66(6.58)
179.55(33.88) 65.77(13.61)

M1

M3

Heel

49.45/ 29.28

45.57 / 10.21

38.54/ 13.26

minimum

13.32

7.70

30.03

18.19

maximum

78.11

105.96

63.61

60.78

The overground trials were averaged to produce characteristic tables which represent the
four areas. Due the robust information collected over the ground, some of the trials were
disregard if the data was overwhelmed by too much noise. As in the trial over the treadmill,
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another knowledge base for female and male was produced out of the average from the control
group. The following tables represent in detailed the pressure information of the male and
female patients and range of magnitudes provide by the knowledge base.

Table 8.3: Male Diabetic patients average of the max press over ground and Knowledge base.
Big Toe
Patients
PM01
PM02
PM03
PM04
PM05

M1

M3

Heel

Right

Left

Right

Left

Right

Left

Right

Left

36.90(7.45)
145.61(27.31)
179.60(8.04)
129.24(27.42)
162.52(4.74)

41.08(7.91)
152.39(12.43)
98.44(20.72)
67.69(13.79)
203.11(29.90)

71.82(19.64)
80.54(6.92)
123.36(13.59)
92.55(5.79)
54.42(5.23)

61.00(16.86)
77.30(4.63)
50.02(7.89)
62.19(4.69)
29.08(9.35)

65.94(2.96)
161.02(15.45)
94.54(14.15)
86.42(22.41)
118.63(5.17)

56.70(17.01)
160.02(21.89)
100.42(14.72)
74.03(07.55)
159.78(11.82)

58.53(20.39)
61.97(3.23)
106.66(14.18)
92.79(4.92)
98.30(14.35)

39.40(11.54)
62.50(1.69)
58.88(8.84)
64.39(2.27)
201.70(38.57)

Healthy Participants
Big Toe

M1

M3

67.93 / 26.44

Heel

mean/std

55.42 /29.29

61.22 / 30.70

83.74 / 23.67

Minimum

14.78

31.83

20.14

55.37

Maximum

125.97

145.24

121.55

139.21

Table 8.4: Female Diabetic patients average of the max press over ground and Knowledge base.

Patients
FDM01
FDM02
FDM03
FDM04
FDM05
FDM06
FDM07
FDM08
FDM09

Big Toe
Right
Left
24.41(2.33)
70.367(13.48)
47.99(9.11)
13.53(2.65)
121.66(45.34) 21.03(6.37)
100.00(40.24) 217.80(50.19)
30.78(3.45)
37.15(7.46)
39.72(10.48)
36.47(11.80)
78.97(18.93)
41.82(8.25)
32.27(8.33)
30.33(2.53)
254.46(38.98) 52.02(3.03)

mean/std

Healthy Participants
Big Toe
58.44 / 42.20

M1
Right
Left
36.71(10.76)
57.68(16.27)
78.14(24.09)
78.18(24.43)
75.65(12.80)
68.67(13.99)
163.24(74.35) 191.19(58.84)
39.24(6.01)
54.45(13.72)
64.37(12.32)
112.07(29.97)
68.08(19.20)
41.63(11.57)
81.32(22.02)
103.71(26.01)
219.22(17.67) 44.13(1.22)

M1
58.36 / 22.09

M3
Right
46.12(14.09)
86.75(23.03)
110.43(9.35)
97.81(40.37)
36.39(4.56)
66.84(13.55)
55.00(6.57)
58.55(15.28)
352.45(40.48)

Heel
Left
61.85(9.18)
70.45(12.90)
107.48(27.22)
92.29(39.19)
47.78(11.40)
112.76(28.24)
36.11(10.68)
60.16(15.58)
65.27(4.55)

M3
42.49 / 15.88

Right
51.62(15.53)
84.14(1.85)
211.75(27.811)
83.05(15.81)
64.45(8.79)
68.41(5.11)
101.0(26.85)
61.42(10.11)
227.12(5.35)

Left
68.67(25.81)
54.43(3.21)
246.38(22.16)
116.44(18.27)
54.89(13.63)
106.52(3.50)
64.60(12.42)
62.35(6.64)
77.28(2.79)

Heel
50.48 / 20.41

minimum

9.66

31.36

18.30

30.17

maximum

132.06

103.33

64.23

94.55
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GRF
The GRF data was resampled once the filtering stage was completed, as well as the data
from the other systems. A matrix was created for each force (Anterior posterior, medio-lateral,
and vertical) from the entire stride. The next step was to extract the most significant
characteristics of these matrixes to create a vector and plot representative trial. A knowledge
base was built for the Vertical, Medio-lateral, and Anterior posterior GRF (for both male and
female). For each of the knowledge base, an average of the left and right leg of all the healthy
participants was performed. As a result of this technique, we produced a matrix and a
representative plot (figure 8.5) for the GRF knowledge base.

Figure 8.5: Male GRF Knowledge base, for Mediolateral (FX), anterioposterior (FY), and
vertical (FZ).
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Figure 8.6: Female GRF Knowledge base, for Mediolateral (FX), anterioposterior (FY), and
vertical (FZ).
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Chapter 9: Discussion
Study Case of Diabetes FP01
Subject is a 56 year old female who was diagnosed with diabetes type 2 five years ago.
From her visit to the study (06/20/2011) her glucose level (fasting) was 260 mg/dL. She is being
medicated with 14 units of insulin per day at the evening. She is not being diagnosed with any
type of peripheral neuropathy.

As mentioned in chapter 6 she walked a 100 seconds over the

treadmill while the three systems were collecting simultaneously her data.
Figure 9.1 illustrates the GRF pattern in the different planes of the FP01 in comparison to
our knowledge base built from the six healthy participants.

Figure 9.1: GRF patter during the gait cycle for FP01 (Green dash) in the Mediolateral,
anterioposterior , and vertical in comparison to control group (blue). Note: both data were
normalized by the body weight.
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The average speed of the control group was .92 m/s, while the speed of FP01 .69 m/s for
right and .70 m/s for left. The low speed during the trial is reflected in the output shapes. In the
vertical (Z axis) plane the characteristic „M‟ shape is more „n‟ due to the slow speed, but still in
amplitude it is 20 Newtons higher than the knowledge base. In the medial lateral plane, the
magnitude is lower with respect to the knowledge base, since the speed is significantly slower.
As found by Paula M.H. Akashi and Robert van Deusre in the vertical force of the right side
there is the characteristic low peak consequence of the delay in the LG.
Figures 9.2 and 9.3 show the pattern of muscle activation during the gait cycle, in the
right and left leg, respectively. These figures show the comparison between our knowledge base
and patient FP01.

Figure 9.2: EMG activation pattern in the right leg, during the gait cycle for, FP01 (Green dash)
in comparison to control group (blue).
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Figure 9.3: EMG activation pattern in the left leg, during the gait cycle for, FP01 (Green) in
comparison to control group (blue).

The muscle activation in the right LG and left VL show a similar delay found by Paula
M.H Akashi and colleagues. Both of the Soleus show an early activation which can be associated
to a drop foot case, commonly found in diabetic patients. Other muscles such as TA-right, GMright, and ES-right are activated at their proper time. The left side muscles show a difference in
the activation time. This could be an indicator of PN.
Table 9.1 represents the average of the pressure in foot sole, over the treadmill, in the
target areas of Heel, Metatarsals 1 & 3, and Big toe. The table below represents the range of
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pressure provided by the minimum and maximum value of the average of the control group. For
each of the targeted areas there is range.
Table 9.1: PF01 average of the max press over the instrumental treadmill and Knowledge base.
Big Toe
Patients
FDM01

M1

M3

Heel

Right

Left

Right

Left

Right

Left

Right

Left

49.00(15.18)

103.18(44.84)

37.22(8.34)

80.40(16.12)

33.10(8.72)

64.52(15.89)

30.52(13.03)

29.95(9.36)

Healthy Participants
Big Toe
mean/std

39.49 / 19.60

M1

M3

49.45 / 29.28

45.57 / 10.21

Heel
38.54 / 13.26

Minimum

13.32

7.70

30.03

18.19

Maximum

78.11

105.96

63.61

60.78

The most affected areas were left Big toe, and left metatarsal one. The rest of the areas
were in the range of the knowledge base. Table 9.2 represents the average pressure of the five
trials over the ground on the different areas, of interest.
Table 9.2: FP01 average of the max press over ground and Knowledge base.

Patients
FDM01

Big Toe
Right
Left
24.41(2.33)
70.367(13.48)

mean/std

Healthy Participants
Big Toe
58.44 / 42.20

M1
Right
Left
36.71(10.76) 57.68(16.27)

M3
Right
Left
46.12(14.09) 61.85(9.18)

Heel
Right
Left
51.62(15.53)
68.67(25.81)

M1
58.36 / 22.09

M3
42.49 / 15.88

Heel
50.48 / 20.41

minimum

9.66

31.36

18.30

30.17

maximum

132.06

103.33

64.23

94.55

As expected the same areas with higher pressure were the big toe and metatarsal one.
SW Monofilament
The feeling sensation of FP01 was tested using a set of monofilaments (4-g/4.31, 10-g
/5.07, and 10-g /5.07). These were the results obtained.
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4-g/4.31

Failed to sense in right metatarsal 3, 5, and heel in the. Also, failed to sense left big toe, in
metatarsal 3, 5, and heel.


10-g /5.07

Failed to sense in the left big toe and left hell.


300-r/6.56

Did not fail to sense any area.

Over view FP01
(A) GRF
In the vertical plane and medio-lateral, FP01 shows a bigger magnitude with respect to the
control group data, especially in the left side. In the right vertical plane there is second low peak
characteristic of the diabetic patients due to a delay in the LG.
(B) EMG
As mentioned from the literature, the GL and VL showed a delay in the activation during the gait
cycle. The muscles of the right leg although some irregularities they were activated at the proper
time. The group of muscles in the left leg showed irregularities during the activation during the
gait cycle.
(C) Pressure in the Foot sole
Even though there is a difference in magnitude between the trial overground and over the
treadmill, in both trials there were irregular high pressures in the left big toe and left metatarsal
one.
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All three systems found irregular details which can be associated to diabetic neuropathy
in the left lower extremity of FP01. Within the results of the monofilament test, it was also found
that areas with low sensitivity have higher pressure.
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Chapter 10: Conclusions, Outcomes and Claims of the Research
Background
There was an extensive investigation of parameter which are associated to the
development of peripheral neuropathy such as irregular high pressure in the foot sole, irregular
muscle activation during the gait cycle, and irregular high magnitude in the ground reaction force
in three different axis.

Objective
The objective was to develop an efficient and reliable measurement of foot ulceration
will provide the required sensory feedback for the brain plasticity.

Outcomes of this research
By implementing the technique of multiple sensors, this investigation successfully found
motor irregularities that might indicate the development of PN in diabetic patients with type 2
diabetes using three sensor systems. The data collected from one sensor system supported and
validated the information from the other sensor and vice versa. As in the study case of FP01 all
three sensor systems confirmed that her left lower extremity had irregular muscular activation
(such delay in the GL), high pressure (in big toe and metatarsal 1), and strong GFR (in the X and
Z plane). PF01 was also tested using the SW monofilaments in the same areas with less feeling
sensation at the same areas with highest pressure found using the Fscan. This system could not
provide a diagnosed of whether a diabetic patient has developed or not PN, but it can provide
reliable and accurate data to medical doctor.
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Claims of this research
[1] It is possible to obtain a reliable and efficient measurement of the diabetic foot by the
use of this innovative technique .
[2] The data collected using multiple sensors sources can provide measurements which
can be used for feedback compensatory strategies.
[3] The data collected over the ground and/or over the treadmill can provide reliable
information to monitor the diabetic foot.
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Chapter 11: Future Work


For future work, it will be necessary to increase the size of the population of patients
and healthy participants.



Healthy patients need to have closer anthropomorphic similarities to the patients.
During the overground trials it is necessary to establish a specific distance, this will
enhance the accuracy of the calculation of the speed.



Incorporate a third group to the investigation, with a population of diabetic patients
with history of diabetic ulceration.



Since there are a set of knowledge base, the next step will be to implement an
intelligent algorithm to establish the difference between the control group and
diabetic patients. At the same time this can also be use to classify the level of severity
of the PN.



Pressure data can enhance by replacing the insole system with a pressure sensor mat.
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Appendix (experimental results without interpretations)
Semmes – Weinstein Monofilament Testing Results Sheet
Gender:_________Age:___________

Name:



1

1


2

3

2

3

4

4





5

1
2

Great Toe
1st metatarsal

3

3rd metatarsal

4

5th metatarsal

5

Heel

1
2

Great Toe
1st metatarsal

3

3rd metatarsal

4

5th metatarsal

5

Heel

5

Bow the 10-g MF at a designated site, and
ask the patient, “Do you feel it touch you –
yes or no?”
Repeat testing twice at each site and
randomly include a “sham” application in
which the 10-g MF is not applied. There will
be a total of three applications at each site,
one of which does not touch the skin.
Protective sensation is considered to be
present if the patient correctly answers two
or more of the three applications, one of
which was a sham.
If the patient correctly answers only one or
none of the three applications, return and
retest that site.
The patient is considered to have insensate
feet if they fail on retesting at just one or
more sites on either foot.

10-g/5.07 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham

2.83 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham
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1
2
3
4
5

1
2
3
4
5

1
2
3
4
5

1
2
3
4
5

3.61 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham

4.31 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham

4.56 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham

6.65 SW Monofilament Test Results
Right
1st
2nd
Sham
1st

Left
2nd

sham

Great Toe
1st metatarsal
3rd metatarsal
5th metatarsal
Heel

Great Toe
1st metatarsal
3rd metatarsal
5th metatarsal
Heel

Great Toe
1st metatarsal
3rd metatarsal
5th metatarsal
Heel

Great Toe
1st metatarsal
3rd metatarsal
5th metatarsal
Heel

Note:
 Normal: 2.83, 3.61, 4.31
 Protective: 4.56, 5.07
 Severe insensitive: 6.65
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Right leg EMG pattern of MP01 in comparison to Knowledge Base

47

Left leg EMG pattern of MP01 in comparison to Knowledge Base

48

Right leg EMG pattern of MP02 in comparison to Knowledge Base

49

Left leg EMG pattern of MP02 in comparison to Knowledge Base

50

Right leg EMG pattern of MP03 in comparison to Knowledge Base

51

Left leg EMG pattern of MP03 in comparison to Knowledge Base

52

Right leg EMG pattern of MP04 in comparison to Knowledge Base

53

Left leg EMG pattern of MP04 in comparison to Knowledge Base

54

Right leg EMG pattern of MP05 in comparison to Knowledge Base

55

Left leg EMG pattern of MP05 in comparison to Knowledge Base

56

Right leg EMG pattern of FP02 in comparison to Knowledge Base

57

Left leg EMG pattern of FP02 in comparison to Knowledge Base

58

Right leg EMG pattern of FP03 in comparison to Knowledge Base

59

Left leg EMG pattern of FP03 in comparison to Knowledge Base

60

Right leg EMG pattern of FP04 in comparison to Knowledge Base

61

Left leg EMG pattern of FP04 in comparison to Knowledge Base

62

Right leg EMG pattern of FP05 in comparison to Knowledge Base

63

Left leg EMG pattern of FP05 in comparison to Knowledge Base

64

Right leg EMG pattern of FP06 in comparison to Knowledge Base

65

Left leg EMG pattern of FP06 in comparison to Knowledge Base

66

Right leg EMG pattern of FP07 in comparison to Knowledge Base

67

Left leg EMG pattern of FP07 in comparison to Knowledge Base

68

Right leg EMG pattern of FP08 in comparison to Knowledge Base

69

Left leg EMG pattern of FP08 in comparison to Knowledge Base

70

GRF pattern of MP01 in comparison to Knowledge Base

71

GRF pattern of MP02 in comparison to Knowledge Base

72

GRF pattern of MP03 in comparison to Knowledge Base

73

GRF pattern of MP05 in comparison to Knowledge Base

74

GRF pattern of FP02 in comparison to Knowledge Base

75

GRF pattern of FP03 in comparison to Knowledge Base

76

GRF pattern of FP04 in comparison to Knowledge Base

77

GRF pattern of FP05 in comparison to Knowledge Base

78

GRF pattern of FP06 in comparison to Knowledge Base

79

GRF pattern of FP07 in comparison to Knowledge Base

80

GRF pattern of FP08 in comparison to Knowledge Base
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